Home › Funds › Michelson Medical Research Foundation, Inc. › KRE

Michelson Medical Research Foundation, Inc. position in KRE

SPDR SERIES TRUST

Michelson Medical Research Foundation, Inc. reported holding 63,510 shares of KRE (SPDR SERIES TRUST) in its Q3 2026 13F filing — a position valued at US$4.4M, representing 3.92% of its reported portfolio and ranking #9 among its reported holdings. Michelson Medical Research Foundation, Inc. has disclosed KRE holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)63.51K sh
Reported value held$4.41M
Portfolio Weight3.92%
First reportedQ3 2023
Last changeHold
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How Michelson Medical Research Foundation, Inc.'s KRE position evolved

Michelson Medical Research Foundation, Inc. first disclosed a stake in KRE in Q3 2023 at 114,700 shares (US$4.8M). The position peaked in Q3 2024 at 114,700 shares, worth US$6.5M. Across 13 filings, Michelson Medical Research Foundation, Inc. increased the stake 0 time(s), trimmed it 2 time(s) and left it unchanged 10 time(s). The most recent filing (Q3 2026) shows 63,510 shares valued at US$4.4M. Notable position changes include a 33% trim in Q4 2024 (shares fell 6% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 114.70K $4.79M New
Q4 2023 114.70K $6.01M Hold
Q1 2024 114.70K $5.77M Hold
Q2 2024 114.70K $5.63M Hold
Q3 2024 114.70K $6.49M Hold
Q4 2024 77.10K $4.65M Reduce
Q1 2025 77.10K $4.38M Hold
Q2 2025 63.51K $3.77M Reduce
Q3 2025 63.51K $4.02M Hold
Q4 2025 63.51K $4.12M Hold
Q1 2026 63.51K $4.14M Hold
Q2 2026 63.51K $4.75M Hold
Q3 2026 63.51K $4.41M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About KRE and 13F data

KRE (SPDR SERIES TRUST) is a company whose sector is not yet classified in our data. 26 other funds we track also report a position in KRE — the largest reported positions include Goldman Sachs Group (US$988.2M), HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND (US$582.3M), MENORA MIVTACHIM HOLDINGS LTD. (US$169.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding KRE

All KRE fund holders →

FAQ

How long has Michelson Medical Research Foundation, Inc. held KRE?

Michelson Medical Research Foundation, Inc. has disclosed KRE holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Michelson Medical Research Foundation, Inc.'s current position in KRE?

As of Q3 2026, Michelson Medical Research Foundation, Inc. holds 63.51K shares of KRE (SPDR SERIES TRUST), valued at $4.41M, representing 3.92% of its reported portfolio and ranking #9.

Has Michelson Medical Research Foundation, Inc. been buying or selling KRE?

In the latest 13F filing (Q3 2026), Michelson Medical Research Foundation, Inc. held unchanged its position in KRE. The position peaked in Q3 2024 at 114.70K shares.

Which other funds hold KRE?

Other major institutional holders of KRE include Goldman Sachs Group, HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND, MENORA MIVTACHIM HOLDINGS LTD., among 26 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.